Aurora Cannabis/$ACB
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Aurora Cannabis
Aurora Cannabis Inc headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company operates in Canada, it has expanded internationally through medical cannabis exporting agreements. The company opertes in Canada, Europe, Australia, and Others, with majority revenue from Canada.
Ticker
$ACB
Sector
Primary listing
Employees
1,073
Headquarters
Edmonton, Canada
Website
Aurora Cannabis Metrics
BasicAdvanced
$301M
-
-$0.23
3.44
-
Price and volume
Market cap
$301M
Beta
3.44
52-week high
$6.91
52-week low
$3.42
Average daily volume
1.9M
Financial strength
Current ratio
2.966
Quick ratio
1.143
Long term debt to equity
6.166
Total debt to equity
17.264
Interest coverage (TTM)
-1.29%
Profitability
EBITDA (TTM)
8.441
Gross margin (TTM)
48.24%
Net profit margin (TTM)
-5.05%
Operating margin (TTM)
-3.03%
Effective tax rate (TTM)
-46.64%
Revenue per employee (TTM)
$234,850
Management effectiveness
Return on assets (TTM)
-0.81%
Return on equity (TTM)
-1.19%
Valuation
Price to revenue (TTM)
1.171
Price to book
0.76
Price to tangible book (TTM)
0.91
Price to free cash flow (TTM)
-419.546
Free cash flow yield (TTM)
-0.24%
Free cash flow per share (TTM)
-0.013
Growth
Revenue change (TTM)
28.58%
Earnings per share change (TTM)
-54.48%
What the Analysts think about Aurora Cannabis
Analyst ratings (Buy, Hold, Sell) for Aurora Cannabis stock.
Bulls say / Bears say
In Q1 FY2026, Aurora reported a 37% year-over-year increase in global medical cannabis net revenue to $64.8 million, driven by an 85% surge in international markets, underscoring strong global demand. (Nasdaq)
In fiscal 2025, the company achieved record adjusted EBITDA of $49.7 million (261% YoY growth) and generated $9.9 million in positive free cash flow, highlighting robust profitability and cash generation. (PR Newswire)
As of Q1 FY2026, Aurora operates its cannabis business debt-free with approximately $186 million in cash on hand, providing financial flexibility for strategic growth. (PR Newswire)
Aurora warned that global cannabis revenue would temporarily decline due to reduced international sales, prompting a more than 17% stock drop and indicating volatility in key markets. (Investopedia)
In Q1 FY2026, consumer cannabis net revenue fell 32% year-over-year to $7.9 million as Aurora prioritized its medical segment, revealing weakness in its consumer business. (Nasdaq)
On June 18, 2025, Aurora’s shares plunged 20.4% and traded about 35% below their 52-week high, reflecting ongoing market skepticism and valuation headwinds. (MarketWatch)
Data summarised monthly by Lightyear AI. Last updated on 6 Oct 2025.
Aurora Cannabis Financial Performance
Revenues and expenses
Aurora Cannabis Earnings Performance
Company profitability
Aurora Cannabis News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Aurora Cannabis stock?
Aurora Cannabis (ACB) has a market cap of $301M as of October 21, 2025.
What is the P/E ratio for Aurora Cannabis stock?
The price to earnings (P/E) ratio for Aurora Cannabis (ACB) stock is 0 as of October 21, 2025.
Does Aurora Cannabis stock pay dividends?
No, Aurora Cannabis (ACB) stock does not pay dividends to its shareholders as of October 21, 2025.
When is the next Aurora Cannabis dividend payment date?
Aurora Cannabis (ACB) stock does not pay dividends to its shareholders.
What is the beta indicator for Aurora Cannabis?
Aurora Cannabis (ACB) has a beta rating of 3.44. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.